noom glp 1 injection Launches Microdose GLP-1 Program, Including Medication and Microhabits Program GLP-1 Microdosing Reshapes Weight Loss

Age also plays a role in adherence, with lower rates observed in younger populations (Chart 6)

In diabetic patients, semaglutide significantly reduced the incidence of cardiovascular events by 26%

Semaglutide is a medication that was initially approved for Type 2 diabetes, but is now allowed to be prescribed for weight loss too

"This convenient once-daily pill with no restrictions on food and water intake could be an option for millions of people with type 2 diabetes who prefer oral medications over injectables," commented Jeff Emmick, head of product development at Lilly

Large clinical trials have reinforced these recommendations